NASDAQ:SXTC - China SXT Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$4.70 -0.30 (-6.00 %)
(As of 01/21/2019 07:43 AM ET)
Previous Close$5.00
Today's Range$4.48 - $5.08
52-Week Range$4.40 - $23.35
Volume57,828 shs
Average Volume175,864 shs
Market Capitalization$105.75 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for China SXT Pharmaceuticals Inc.

Receive SXTC News and Ratings via Email

Sign-up to receive the latest news and ratings for SXTC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SXTC
CUSIPN/A
Phone86-523-8629-8290

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees105
Market Cap$105.75 million
OptionableNot Optionable

China SXT Pharmaceuticals (NASDAQ:SXTC) Frequently Asked Questions

What is China SXT Pharmaceuticals' stock symbol?

China SXT Pharmaceuticals trades on the NASDAQ under the ticker symbol "SXTC."

Has China SXT Pharmaceuticals been receiving favorable news coverage?

Media coverage about SXTC stock has trended positive this week, according to InfoTrie. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. China SXT Pharmaceuticals earned a news impact score of 2.7 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 1.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future.

Who are some of China SXT Pharmaceuticals' key competitors?

When does the company's quiet period expire?

China SXT Pharmaceuticals' quiet period expires on Wednesday, February 13th. China SXT Pharmaceuticals had issued 2,546,275 shares in its initial public offering on January 4th. The total size of the offering was $10,185,100 based on an initial share price of $4.00. During the company's quiet period, underwriters and any insiders involved in the IPO are prevented from issuing any earnings forecasts or research reports for the company because of SEC regulations. Following the expiration of the company's quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.

How do I buy shares of China SXT Pharmaceuticals?

Shares of SXTC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China SXT Pharmaceuticals' stock price today?

One share of SXTC stock can currently be purchased for approximately $4.70.

How big of a company is China SXT Pharmaceuticals?

China SXT Pharmaceuticals has a market capitalization of $105.75 million. China SXT Pharmaceuticals employs 105 workers across the globe.

What is China SXT Pharmaceuticals' official website?

The official website for China SXT Pharmaceuticals is http://www.sxtchina.com.

How can I contact China SXT Pharmaceuticals?

China SXT Pharmaceuticals' mailing address is 178 TAIDONG ROAD NORTH, TAIZHOU F4, 225300. The company can be reached via phone at 86-523-8629-8290 or via email at [email protected]


MarketBeat Community Rating for China SXT Pharmaceuticals (NASDAQ SXTC)

Community Ranking:  0.9 out of 5 ()
Outperform Votes:  2 (Vote Outperform)
Underperform Votes:  9 (Vote Underperform)
Total Votes:  11
MarketBeat's community ratings are surveys of what our community members think about China SXT Pharmaceuticals and other stocks. Vote "Outperform" if you believe SXTC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SXTC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2019 by MarketBeat.com Staff

Featured Article: Inflation

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel